Prognostic indicators for undifferentiated carcinoma with/without osteoclast-like giant cells of the pancreas
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic CancerNew England Journal of Medicine, 2018
- Anaplastic carcinoma of the pancreas diagnosed by endoscopic ultrasound-guided fine-needle aspiration: a case report and review of the literatureJournal of Medical Case Reports, 2018
- Using the National Cancer Database for Outcomes ResearchJAMA Oncology, 2017
- Staging of pancreatic cancer based on the number of positive lymph nodesBritish Journal of Surgery, 2017
- Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic CancerJAMA, 2013
- Clinical Outcomes for Anaplastic Pancreatic Cancer: A Population-Based StudyJournal of the American College of Surgeons, 2012
- Undifferentiated Carcinoma of the Pancreas With/Without Osteoclast-Like Giant CellsPathology Case Reviews, 2010
- A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic CancerNew England Journal of Medicine, 2004
- A clinicopathologic and immunohistochemical study of 35 anaplastic carcinomas of the pancreas with a review of the literatureAnnals of Diagnostic Pathology, 2001
- Pleomorphic Carcinoma of the Pancreas: Reappraisal of Surgical ResectionAmerican Journal of Gastroenterology, 1998